Selling Stockholders Offer 35M Shares; Company to Repurchase 6M from Offering

summarizeSummary

Selling stockholders are offering 35 million shares, but LifeStance Health Group will repurchase 6 million shares from the offering, resulting in a net increase of 29 million shares in the market.

check_boxKey Events

• Secondary Offering by Selling Stockholders

  Selling stockholders are offering 35,000,000 shares of common stock. The company will not receive any proceeds from this sale.

• Company Share Repurchase

  LifeStance Health Group intends to repurchase 6,000,000 shares of its common stock from the underwriter at the offering price, using cash on hand. This repurchase is part of a previously announced program.

• Net Dilution Impact

  The offering, net of the company's repurchase, will add 29,000,000 shares to the market, representing approximately 7.48% of the company's outstanding shares.

• Offering Price and Market Context

  The offering was priced at $8.00 per share (as reported by news), which is a premium to the $7.36 closing price on May 6, 2026, and follows strong Q1 2026 financial results.

auto_awesomeAnalysis

This preliminary prospectus supplement details a secondary offering of 35 million shares by selling stockholders, from which LifeStance Health Group will not receive any proceeds. Crucially, the company announced its intent to repurchase 6 million shares from this offering using cash on hand, reducing the net number of shares entering the market to 29 million. This net increase represents approximately 7.48% of the company's outstanding shares. While secondary offerings by existing shareholders can create an overhang, the company's repurchase mitigates the dilutive impact and signals confidence, especially following strong Q1 2026 financial results reported earlier this week. The offering was priced at $8.00 per share (as reported by news), a premium to the $7.36 closing price on May 6, 2026, indicating solid demand for the shares.